Postbiotic as Adjunct Treatment for Vaginal Candidiasis
NCT: NCT06474247 · COMPLETED
NCT IDNCT06474247
StatusCOMPLETED
Start Date2024-06-02
Completion2026-04-30
SponsorMin-Tze LIONG (OTHER)
First posted
Last updated
Brief Summary
This project aims to study the efficacy of oral administration of postbiotic at 1g/day as an adjunct treatment against vaginal candidiasis in women for 4-weeks compared to placebo.
Frequently Asked Questions
What is Postbiotic as Adjunct Treatment for Vaginal Candidiasis?
Postbiotic as Adjunct Treatment for Vaginal Candidiasis is a clinical trial registered under NCT06474247. Current status: COMPLETED.
What is the status of NCT06474247?
The current status of NCT06474247 (Postbiotic as Adjunct Treatment for Vaginal Candidiasis) is: COMPLETED.
When did Postbiotic as Adjunct Treatment for Vaginal Candidiasis start?
Postbiotic as Adjunct Treatment for Vaginal Candidiasis started on 2024-06-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.